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Abstract
As vast amounts of unstructured data are becoming available digitally, computer-based
methods to extract relevant and meaningful information are needed. Information Extraction (IE)
is the process of extracting relevant, useful, structured pieces of information from unstructured
text. This field has been gaining a lot of attention from the scientific research community over
the last period.
Named entity recognition (NER) is the task of identifying text spans that represent
named entities, and to classify them into predefined categories. The NER task is one of the
fundamental tasks in the information extraction domain and can be an initial step towards other
tasks. A lot of research has been done in efforts to build better NER systems. Despite the
existence of numerous and well-versed NER methods, they mainly focus on generic NER rather
domain specific NER; NER tasks for biomedical domain remain under-studied. This research
will be focusing on extracting relevant named entities from biomedical data.
The objective of this research is to identify an efficient technique for NER tasks from
biomedical data. This is achieved by investigating using deep learning technologies namely pretrained BERT [1] model and its variances SciBERT [2] and BioBERT [3]. Preprocessing the data
before passing it for training influences model performance. There is also investigation with
some preprocessing rules to monitor their effect on model performance.
To conduct this research, we built a baseline system and held different experiments to
explore how changing certain factors would affect the results. Baseline system is initialized with
BERT base model and it is finetuned on the ChemProt dataset [4] for 3 epochs with learning rate
3e-05, Precision: 24.27%, Recall: 27.87%, F1: 25.94%. Based on the conducted experiments our
findings are that initializing the system with SciBERT pre trained model and fine tuning it with
ChemProt dataset has better results over other BERT variations. We also found out that
applying preprocessing to the training data has a significant positive impact over model
performance. Also, with the release of DrugProt [5] dataset, a newer version of ChemProt
dataset we have the chance of increasing the training data which also have a positive impact
over model performance. Our contribution is benchmarking for ChemProt dataset and building
a baseline system for further research. Also, applying POS tagging in data preprocessing step
helps filter out less relevant parts of text which improves model performance. The best
2

performance could be achieved by removing punctuation, stop words verbs and adjectives from
the text and finetuning SciBERT pretrained model on DrugProt [5] with learning rate 3e-5 for 3
epochs, token level evaluation: Precision: 66.20%, Recall: 98.96%, F1: 79.33%, entity level
evaluation: Precision: 47.62%, Recall: 77.34%, F1: 58.95%.
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Chapter 1

Introduction
Information extraction is the process of data scanning looking for relevant pieces of
information. Automated information extraction systems help in saving significant time and
effort when getting specific information in a short time. With the recent medical challenges, we
have been facing, it would be much easier to be up to speed and gain information that would
help in overcoming these challenges by scanning the thousands of digitally available medical
documents and extracting relevant information.
The problem at hand is extracting named entities from unstructured biomedical text and
classifying them into pre-defined categories. Named entity recognition (NER) is a widely
applicable natural language processing task and building block of question answering, topic
modeling, information retrieval, etc. In the medical domain, NER plays a crucial role by
extracting meaningful chunks from clinical notes and reports, which are then fed to
downstream tasks like assertion status detection, entity resolution, relation extraction, and deidentification.
The following subsections elaborate more on the problem definition, and what is the
scope of work we are doing. We will also go over background about named entity recognition
(NER) and the document layout.

1.1 Problem definition
With the abundance of information on the internet, a great opportunity is presenting
itself for being more educated and well informed. However, this comes with a drawback, that
the data is not necessarily structured and extracting a relevant piece of information is becoming
a challenging task. Different research has been concerned with extraction of useful structured
information from unstructured information. Information extraction can be considered under the
wide umbrella of text understanding. While in text understanding the main objective is to
represent all information that can be found in the text, information extraction focuses on the
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extraction of specific se-mantic information related to the extraction task [6]. Information
extraction is used widely in extracting specific information from many documents, it is applied
to scientific journals, hospital records, legal contracts, news records, etc. Applying information
extraction helps reduce the human effort of going through many documents to extract answers
to specific queries or relations between entities.
Though a lot of research has been done in the field of information extraction from text,
fewer research was done for domain specific information extraction. Domain data is different in
the sense of explicit terms that mean different things in different contexts and terms that are not
common in everyday life.
The task of named entity recognition (NER) is probably the first step towards
information extraction. Named entities extracted from text could be fed into a relation
extraction task to extract relations between 2 entities. The presence of certain entities could also
be an indication of a certain text classification. NER systems work by ingesting the input text
and looking for named entities to extract and classify them into one of the predefined
categories. There are two types of Named Entities (NE), Generic named entities like names of
persons, organizations, locations, etc. and Domain Specific Named Entities like in the field of
biomedical data, drug names, protein names, chemicals, etc.
This research will be focusing on extracting and classifying named entities from
biomedical data.

1.2 Background
The origin of the term “Named Entity” (NE) was first introduced by R. Grishman and B.
Sundheim in 1996, their main task was to identify names of all the people, organizations, and
geographic locations in a text [7]. Later on, Petasis et al. [8] continued the work by limiting the
definition of a named entity to proper nouns serving only as a name for something or someone.
Following their work, there has been numerous efforts among researchers trying to settle on the
type of nouns to be classified as NE. They came to agree on dividing NEs into two categories,
generic NEs and domain specific NEs. Generic NEs like people names, locations, organizations,

11

etc. and Domain specific NEs to be defined according to the domain in question e.g., in
biomedical domain proteins, drug names, diseases, etc. should be categorized as Named
entities.
Named Entity Recognition and Classification (NERC), is the process of extracting and
locating named entities within a text and classifying them into the different categories: person,
organization, location, etc. It is considered to be an important step for text pre-processing and a
vital phase in the process of Information Extraction (IE) [9].

1.3 Research objective
The objective of this research is to identify an efficient approach for extracting named
entities from biomedical text and investigate the effects of applying different preprocessing
methods on text before sending to the model.

1.4 Document Layout
This document contains the following chapters:
Chapter2 - Literature review: In this chapter we investigate what has already been done
in the field. We also explore the related works to learn more about state-of-the-art technologies.
Chapter 3 – Research objective and methodology: In this chapter we highlight the main
objective of this research. State the research questions and the steps to answer them.
Chapter 4 – Baseline system: In this chapter we give an overview of the dataset used, the
data preparation steps. We will go over the model setup and the evaluation metrics used.
Chapter 5 – Experimentations: In this chapter we highlight the experiments conducted
throughout this research, each experiment contains the hypothesis, setup observations, and
results.
Chapter 6 - Conclusion and Future work: In this section we highlight our findings,
conclusion and the future work proposed for this research.
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Chapter 2

Literature review
NER techniques can be divided into two main approaches supervised and unsupervised
learning approached. Supervised learning approaches are split into rule-based, feature-based,
and deep learning approaches. In this section we through light on all the approaches that are
presented.

2.1 Supervised learning approach
2.1.1 Rule based approach
This approach mainly relies on designed rules [10] thus no need for the presence of
annotated data. Rules can be crafted according to the domain in question, based on common
dictionaries in the domain [11] or syntactic-lexical patterns yielding better results in the cases of
restricted domains. An example from the biomedical domain is ProMiner [12] which builds on a
previously available dictionary of synonyms. It was initially proposed to help in the problem of
identification of proteins and their gene names in text. The ProMiner system consists of three
parts: dictionary generation, occurrence detection and filtering of matches. The first part is
about generating a name dictionary by associating each biological entity with all known
synonyms. The second part of the system is a highly sensitive search procedure that aims to
detect all potential occurrences of a named entity and its synonyms in the text. The last part is
for filtering and disambiguation to identify different types of named entities.
A drawback for this approach is the necessity of human expertise in the domain in
question along with programming skills [13]. This approach consumes too much effort to
design the system and fine tune it to a specific domain or application. In addition, it will not
perform as good in a different domain [14]. Precision is generally high for these systems
because of the lexicon; however, recall is often low because of domain and language-specific
rules and often incomplete dictionaries [15].
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2.1.2 Feature-based approach
These approaches are built on a carefully designed features set where each of them is
engineered to represent a training example [20]. The feature engineering step is very crucial to
the system. Features can be divided into 3 categories:
• Word-level features: if a word window of length five is used then five different
features are considered which are w0 (current word), w−1 (previous word), w+1
(next word), w−2 and w+2. These five features form a feature group (forward word).
• Lexical features: Kazama et al. [21] selected the most frequent 10,000 words from the
GENIA corpus as lexical features for the NE recognizer. The lexical feature set
consists of three term lists: a single-term list, a functional-term list, and a general-term
list. The single term list is a list of single words that can be used as an entity by itself.
Functional term list is a list of terms that are devised to describe the function and
characteristics of named entities. General terms are all terms that are classified neither
as single terms nor function terms. There is no specific lexicon for general terms.
• Orthographical and morphological features: Orthographical features can be used for
words that appear with very low frequency in the training corpus to alleviate the data
sparseness problem.
These features shall be the seed of training in supervised machine learning algorithms
like Support Vector Machines (SVM) [22], Conditional Random Fields [23], and Hidden Markov
Models (HMM) [24].

2.1.3

Deep learning approach

Recently, DL-based approaches became the core of modern NER systems. Its main
merits are the automatic identification of features as opposed to feature-based approaches and
making the system more robust to domain change as opposed to rule-based approaches. A
typical deep learning model consists of multiple layers of neural networks built on top of each
other. These neural networks typically do a forward pass and a backward pass. In the forward
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pass the weighted sum of the inputs is computed and passed through a nonlinear function. The
backward pass computes the gradient of the function given the weights of the modules using
the chain rule of derivatives [25]. The core Strengths of Deep Learning:
• Non-linear transformation, this produces non-linear mappings between the input and
output which enables complex features learning yielding better results compared with
linear models
• Deep Learning requires significantly less effort in feature design, it is effective in
automating the learning of related representations.
• DL models can be trained end-to-end by gradient descent which enables more complex
NER systems.
Convolution neural networks (CNN), recurrent neural networks (RNN), and their
variant networks are the main application networks of this method. The application of
convolutional neural networks to named entity recognition tasks was originally proposed by
Collobert in 2019 [26]. Besides traditional convolutional neural networks, re-current neural
networks have also been widely used in named entity recognition tasks. Several scholars opted
to use a series of long-short-term memory network-based models, such as LSTM, BI-LSTM, and
others [27].
2.1.3.1 KV-PLM, a unified pre-trained language model
KV-PLM [28], a unified pre-trained language model processing both molecule structures
and biomedical text for knowledgeable and versatile machine reading. KV-PLM was developed
by researchers at Tsinghua University, Beijing, China. KV-PLM takes the BERT[1] language
model as its backbone. For the system to process the heterogeneous data in a unified model, it
serializes molecule structures into SMILES [29] strings segment them using the BPE [30]
algorithm. Then the system is pretrained using BERT masked language modeling task to learn
the meta-knowledge between different semantic units. In the training phase, parts of the input
tokens) are randomly masked, and the model is asked to reconstruct the masked tokens
according to the context. In this way, the model can grasp the correlation between molecule
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structure and biomedical text without any annotated data.

2.2 Unsupervised approach
The NLP research community has invested a lot of efforts in unsupervised approaches
for these approaches do not rely on hand-labeled data. Unsupervised approaches aim to use
automated algorithms to extract named entities from the text without relying on external
resources or human intervention. A typical use case for this scenario is clustering. Early works
rely on heuristics rules and lexical resources [16] [17] [18]. Zhang and Elhadad [19] introduced a
novel unsupervised approach for NE extraction in the biomedical field. Their system opts to use
terminologies and corpus statistics and minimal syntactic knowledge as a replacement for
supervision. The first step in their system is seed term collection. In this step a dictionary is
collected for each entity; this dictionary is supposed to contain a set of known terms for each
class. Second step in boundary detection; by using a noun phrase chunker and inverse
document frequency calculation. Then by filtering the noun phrases whose IDF value is lower
than a certain threshold. Third step is entity classification; in this step a signature for each class
is calculated and then a cosine similarity is calculated between each candidate word and a
certain class signature. Based on the similarity calculation each word is assigned a class
accordingly. If the similarity of the word to all classes is lower than the threshold, it is removed
from the set of recognized named entities.

2.3 Hybrid approach
With the continuous advancements that are going in the named entity recognition field,
a lot of researchers have a direction of utilizing a collection of the previous approaches, hybrid
approach. By combining two or more approaches from the previous ones, researchers are able
to overcome the limitations of each of them and capitalize on the strengths of each approach.
2.3.1 LSTM-CRF
Based on the methods suggested by Lample et al [31], research in Humboldt university
in Berlin developed a domain-independent NER system that is independent of any kind of
background knowledge. LSTM-CRF [32] combines the power of word embeddings, LSTMs and
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CRFs into a single method for biomedical NER. The proposed method is completely agnostic to
the type of the entity; all it requires is annotated data and word embeddings pre-computed on a
large biomedical corpus. The system is comprised of three main layers. The first layer is the
embedding layer which receives the raw sentence S made of the sequence of words and
produces an embedding for each word in S. These are fed into a bi-directional LSTM-layer that
produces a refined representation of the input, which is the input to a final CRF-layer.
2.3.2 BioNER
BioNER [27] combines a bi- directional LSTM network and a CRF network to form an BILSTM-CRF model. In addition to the past input features and sentence level tag information
used in a typical LSTM-CRF model, a BI-LSTM-CRF model can use the future input features.
The input data is passed to a POS module that assigns each word with a unique tag that
indicates its syntactic role. In chunking, each word is tagged with its phrase type. For example,
tag B-NP indicates a word starting a noun phrase. Then comes the phase of feature extraction,
spelling features and context features are extracted. Then comes a layer of word embedding that
plays a vital role in improving sequence tagging performance. BioNER is robust, and it has less
dependence on word embedding as compared to the observation made by Collobert et al. [26].
2.3.3 XLNet-CRF
XLNet-CRF [33] uses XLNet [34] based on Self-Attention Permutation Language Model
(PLM) to replace BERT as encoder in the pre-training phase. This avoids the problem of input
noise from autoencoding language model (AutoEncoder LM). When fine-tuning the BioNER
task, the output of the XLNet model is decoded with conditional random field (CRF) decoder.
Because XLNet uses tagged input, the connection layer between XLNet and CRF is tuned with
Label [X]. At first, text is serialized, and the input sequence is generated by the SentiencePiece
[35] based on the input text. Then, the input is word-embedded, and each input character is
mapped to a vector which is the input to the following the multi-header attention model.
Finally, the output vector of the final XLNet model after the attention model is linked by the n
layer residue to the CRF layer which is used as the decoding layer to select the most appropriate
label from the label collection. A is defined as a transition matrix to modify the current forecast
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based on previous label information.

2.4 Ensemble classifiers

Figure 1 Ensemble classifiers

Ensemble classifiers combine the results of several models to improve the results by the
collective system. Utilizing different models enables the collective system to have a better
predictive performance compared to a single model. As shown in Figure 1, the basic idea is to
get the predictions from multiple models and allow them to vote to reach a final consensus for
the prediction. The most challenging part of ensemble classifiers is not finding good performing
model, it is finding models that make different types of mistakes. This way the ensemble system
can build on the strengths of all the underlying models.
Perhaps one of the earliest works on ensemble systems was the work discussed
partitioning the feature space using two or more classifiers [36]. For biomedical NER Zhou et
al., [37] proposed an ensemble of classifiers in which they used Support Vector Machine (SVM)
and two discriminative Hidden Markov Models (HMM), and applied a weighted majority
voting strategy to combine the output of the classifiers, which led to an improved F1 score.
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Chapter 3

Research objective and methodology
In the following sections we state the research objective and the research questions we
are trying to answer throughout this research. We also highlight the steps followed to answer
the research questions.

3.1 Research objective
The objective of this research is to identify an efficient approach for extracting named
entities from biomedical text and investigate the effects of applying different preprocessing
methods on text before sending to the model.
To achieve this objective a set of research questions is proposed:
1.

Will using a specific version of pretrained models of BERT like SciBERT or BioBERT
lead to efficiently extracting named entities from biomedical text?

2.

Will using different methods in preprocessing improve the model performance?

3.

Does increasing the size of training data improve performance.

4.

Does using ensemble classifiers improve scores?

5.

Does building a multi-level hierarchical extraction model improve model
performance?

3.2 Research methodology
In this section we highlight the proposed methodology to answer the research questions.
To answer the first research question, we will follow the first two steps, and to answer the
second research question we will apply the third step. To answer the third question, we will
follow the fourth step. To answer the fourth question, we will follow the fifth step.
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1.

Build a baseline system, initialize it with BERT base model, and train it on a
biomedical dataset.

2.

Use the same setup, initialize the model with SciBERT and BioBERT pretrained
models, observe the change in evaluation scores.

3.

Apply different preprocessing methods and observe changes in overall model
performance.

4.

Experiment increasing training data by using DrugProt dataset[5].

5.

Build an ensemble classification model to combine predictions from more than one
model.

6.

Build a 2-level hierarchical extraction model.

In the following subsections we will provide more details about each of the steps. An overview
of the baseline systems and BERT variations that will be used throughout the research. We will
also go over the rules and tools used in the preprocessing step. For post processing, we will
provide the purpose of this step and the rules. The datasets and evaluation method are also
described.
3.2.1 Baseline system
As a part of this research, we will be building an NER system as a test bed for our
experiments. The Baseline system is expected to extract pre-defined, domain-specific named
entities from biomedical unstructured text. We will be using BERT-based model for this task,
and we will use the ChemProt [4] dataset for benchmarking.
3.2.2 BERT Variations
Since the release of the BERT model, a lot of researchers have increased interest in
creating domain specific versions of BERT. In the research we will focus mainly on SciBERT and
BioBERT since they are finetuned with data for biomedical domain.
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BioBERT
Bio BERT [3] is a variation of the BERT model from Korea University and Clova AI. It
basically has the same structure as BERT. It is initialized with weights from BERT, which was
pre-trained on general domain corpora. Then, BioBERT is trained with biomedical domain
corpora (PubMed abstracts and PMC full-text articles). PubMed is a database of biomedical
citations and abstractions, whereas PMC is an electronic archive of full-text journal articles.
Their contributions were a biomedical language representation model that could manage tasks
such as relation extraction and drug discovery to name a few. By having a pre-trained model
that encompasses both general and biomedical domain corpora, developers and practitioners
could now encapsulate biomedical terms that would have been incredibly difficult for a general
language model to comprehend.
SciBERT
SciBERT [2] is a pre-trained BERT-based language model for performing scientific tasks in
the field of Natural Language Processing (NLP). It was introduced by researchers at the Allen
Institute for Artificial Intelligence (AllenAI) in September 2019. SciBERT follows the same
architecture as BERT but trained on scientific text instead of general corpora. There are 4
different versions of SCIBERT: `basevocab_cased`, `basevocab_uncased`, `scivocab_cased` and
`scivocab_uncased`. The `basevocab` models are initialized with BERT model and finetuned on
the scientific data. The `scivocab` models are trained from scratch on the scientific corpora.
SciBERT is trained on a large multi-domain corpus of scientific publications to improve
performance on downstream scientific NLP tasks. SciBERT is trained on a random sample of
1.14M papers from Semantic Scholar [38]. This corpus consists of 18% papers from the computer
science domain and 82% from the broad biomedical domain.
3.2.3 Preprocessing
In natural language processing, text preprocessing is the practice of cleaning and
preparing text data before using it to the needed task. The goal of cleaning and preparing text
data is to reduce the text to only the words that you need for the task. Preprocessing the data
before feeding it into the model could play an important role in model performance.
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Tokenization is one of the most basic yet fundamental tasks in text preprocessing. Tokenization
is the process of breaking down a piece of text into small units called tokens. A token may be a
word, part of a word or just characters like punctuation. Preprocessing of data could follow on
the following themes, data cleaning/filtering, data ordering or data augmentation, etc. Data
cleaning is the process of adding missing data and correcting, repairing, or removing incorrect
or irrelevant parts in the data. Data filtering is the process of removing parts of the data based
on the filtering conditions applied. Data ordering is the process of arranging the data into some
meaningful order to make it easier to understand, analyze or visualize. Data augmentation is
the process of adding extra indicators or pointers to your data that should not alter your data
itself or remove from it.
For the data preparation step for this research, we start off by tokenizing the named
entities in the dataset and the abstracts. As a result of the tokenization step, labeled named
entities in the dataset are split into one or more tokens. We have to expand the labels to cover
the new tokenization entities for that we apply some basic data augmentation by using the BIO
(Beginning, Inside, Outside) format [39] to augment labels of the entities that could be
composed of more than one token. The first token would have “B-” prefix to their label and all
subsequent labels will have “I-” prefix to their label, all other tokens that are not an entity are
labelled “O”. BIO format is a common format for chunking tags and tokens in NER tasks. An
example of this process is given in Figure 2.

Figure 2 Data preprocessing
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For data filtering, we investigate the effect of adding some basic preprocessing rules like
dropping out punctuation, white spaces and stop words (articles, pronouns, prepositions, and
conjunctions). We also investigate removing irrelevant parts of text based on part-of-speech
tagging. Part-of-speech tagging (POS tagging) aims to identify which grammatical group a
word belongs to, i.e., whether it is a noun, adjective, verb, adverb, etc., based on the context.
For the POS tagger we use the common Natural Language Toolkit (NLTK) [40]. It takes a
sentence as input and returns back list of tokens and their respective POS tags (e.g., NN (noun,
singular or mass), VB (verb, base form), and VBD (verb, past tense)) [41], [42], [43] Based on the
tags returned by POS tagging we remove the adjectives and verbs (not likely to be named
entities) from the training data before passing to the model.
3.2.4 Datasets
With the release of a newer version of ChemProt [4] dataset, the DrugProt [5] dataset,
there is a chance to increase the size of the training set. The newly released dataset only contains
a training set consisting of 3,500 abstracts with 195,000 labeled entities which is a superset of the
chemprot training set; we will use the development and test sets of the chemprot set for
validation and testing.
3.2.5 Evaluation
For the evaluation process we used the same data preparation steps for the model. Then
we pass the list of tokenized abstracts to the system to predict labels for each token. The output
of this process is a list of predicted labels for each input token respectively. We will be using 2
evaluation methods, the first one is token level, second one in entity level. The first method is
simple, we compare the list of predicted labels to the list of expected tokens and calculate the
metrics. For the second method, since each named entity can be broken down into multiple
tokens and the model is trained on the token level and thus generates prediction on token level.
So, to compute entity level evaluation, we will be grouping the token of the named entity and
assign them a single label (based on the majority of the labeled tokens). This method
guarantees that the whole named entity is extracted and given the correct class.
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Given True Positive (TP): where prediction is the same as ground truth and both are not
“O”, True Negative (TN): where prediction is the same as ground truth and both are “O”, False
Positive (FP): where prediction is not the same as ground truth and prediction is not “O” and
False Negative (FN): where prediction is not the same as ground truth, and the prediction is
“O”. Based on these definitions the count of TP, TN, FP and FN, a confusion matrix is
constructed as shown in Figure 3 and evaluation metrics are calculated.

TP

FN

Prediction == Ground truth
Prediction != “O”

Prediction != Ground truth
Prediction == “O”

FP

TN

Prediction != Ground truth
Prediction != “O”

Prediction == Ground truth
Prediction == “O”

Figure 3 Confusion matrix

Precision is the measure of how precise/accurate the system is. It is the ratio between
the True Positives and all the Positives. Precision reveals out of predicted positive entities, how
many of them are actual positive (belong to the right entity type as predicted). Precision = TP /
(TP+FP).
Recall is the measure of the model's ability to extract actual positive entities. It is the
ratio between the predicted True Positives and the labeled positives. Recall reveals out of actual
tagged entities, how many of them are predicted correctly. Recall = TP / (TP+ FN).
F1 Score is a combination of the Precision and Recall metrics, which measures the
overall performance of the model. F1 Score = (2*Precision*Recall) / (Precision + Recall).
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Chapter 4
Baseline system
The following section will elaborate on the development of the baseline system. The
benchmark dataset will be described, the data preparation will be explained, and steps for
building the model are elaborated, and the evaluating metrics will be given.

4.1 Biocreative VI ChemProt
Biocreative VI ChemProt dataset [4], consists of abstracts of biomedical papers collected
from PubMed. For each abstract there is a list of entities with their indices and respective labels.
Each entity is tagged as a Chemical, Gene-Y or Gene-N. GENE-Y is a gene/protein mention
type that can be normalized or associated to a biological database identifier while GENE-N is
gene/protein mention type that cannot be normalized to a database identifier. You can see a
sample of the abstract’s files in Table 1 below, each abstract entry contains the abstract ID, title,
and the abstracts text.
Table 1 Sample of abstracts
Abstract id
23552263

Title

Abstract text

Lipoxygenase and

Over expression of lipoxygenase (LOX) and urease

urease inhibition of

has already contributed to the pathology of different

the aerial parts of the

human disease. Targeting the inhibition of these

Polygonatum

enzymes has proved great clinical utility. The aim of

verticillatum.

the present study was to scrutinise the inhibitory
profile of the aerial parts of the Polygonatum
verticillatum enzyme against LOX, urease,
acetylcholinesterase (AChE) and
butyrylcholinesterase (BChE) using standard
experimental protocols……...
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Table 2 contains part of the entities file; each entry contains the abstract ID where the
entity is observed entity ID with is a sequential identifier for entities per abstract. Entity label
and start and end offsets of the entity and the entity text itself.
Table 2 Sample of entities file
Abstract id
23552263

Entity id
T1

Entity label
CHEMICAL

Start offset
1090

End offset
1097

Entity name
tannins

23552263

T2

CHEMICAL

1102

1112

terpenoids

23552263

T3

CHEMICAL

646

659

ethyl acetate

23552263

T4

CHEMICAL

822

831

n-butanol

23552263

T5

CHEMICAL

1048

1056

saponins

23552263

T6

CHEMICAL

1069

1079

flavonoids

23552263

T7

CHEMICAL

1081

1088

phenols

23552263

T8

GENE-N

108

120

lipoxygenase

23552263

T9

GENE-N

122

125

LOX

23552263

T10

GENE-N

423

426

LOX

23552263

T11

GENE-N

428

434

urease

23552263

T12

GENE-Y

436

456

acetylcholinest
erase

23552263

T13

GENE-Y

458

462

AChE

23552263

T14

GENE-Y

468

489

Butyrylcholine
sterase

23552263

T15

GENE-Y

491

495

BChE

3552263

T16

GENE-N

131

137

urease

23552263

T17

GENE-N

557

569

lipoxygenase

23552263

T18

GENE-N

803

809

urease
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Data is split into 3 sets: train, development, and test. The training set consists of 1020
abstract records with 25,752 labeled entities. The development set consists of 612 abstract
records with 15,567 labeled entities. The test set consists of 900 abstract records with 20,828
labeled entities.
The data provided consists of two files in tab separated formats. One file includes the
abstracts along with their IDs and paper titles. The second file includes the annotated chemical
and gene entities mentioned in each abstract.

4.2 Data preparation
Based on the above section describing how data is available in the ChemProt dataset, we
did the following. We started by importing the entities file and making a list of all the entities
available in our data and each can be found in which abstract. Entities sometimes span more
than one token and since we are doing token level labeling, we need to tokenize the entities and
their labels as well to match our design. For this we used the BIO (Beginning, Inside, Outside)
schema; the first token would have “B-” prefix to their label and all subsequent labels will have
“I-” prefix to their label, all other tokens that are not an entity are labelled “O”. Next, we
tokenize the abstracts and for each token we assign a label based on the created entity labels list.
Figure 4 shows the construction of the entities’ labels list with BIO schema.

Figure 4 Data preparation - entities
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After constructing the list of entities, we get to tokenize each abstract and label it. This
can be elaborated in Figure 5.

Figure 65 Data preparation - abstracts

The input to the model is two lists, one of tokenized abstracts and one is list of labelled
abstracts. Each entry in the first list is a list of tokens in an abstract and each entry in the second
abstract is a list of labels corresponding to the tokens in the first list. You can observe the format
in Figure 6.

Figure 6 Model data input format
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4.3 Initializing the model
We use the same architecture as BERT models which is a Transformer block of 12 layers,
a hidden block of 768 layers with ReLU activation function then a self-attention block of 12
layers and an output layer with SoftMax activation function and the model’s loss function is
Cross-Entropy function. The BERT model architecture can be seen in Figure 7 [1].

Figure 7 BERT model architecture

4.4 Running the model
After prepping the training data and initializing the model we do parameter tuning to
find optimal parameters to train the model with. After initializing the model with BERT base
model, we train it for one of the following epochs counts (3, 8 ,20) with one of the following
learning rates (3e-4, 8e-5, 3e-5, 3e-6). We use the ChemProt training set for training and the
development set for evaluation. Based on the results of the tuning step the optimal model
parameter are 3 epochs and learning rate of 3e-5. Then we use the training and development set
for training and the test for testing. Table 3 shows the baseline evaluation scores.
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Table 3 Baseline evaluation scores
Token level eval
BERT (Baseline)

Precision
24.27%

Recall
27.87%

F1 Score
25.94%

4.5 Remarks
The observed results for the baseline system are way lower than expected. This is
because we initialized the baseline system using the vanilla BERT model which is trained on
general domain corpora and there was no preprocessing of any sorts for the data.
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Chapter 5

Experimentations
In this chapter we highlight the experiments conducted throughout this research, each
experiment contains the hypothesis, setup observations, and results. These experiments use
bert-sklearn [44] which is scikit-learn wrapper for BERT based on the Hugging Face [45] and
PyTorch [46] port. We run these experiments on Amazon Elastic Compute Cloud P3 machines.
The machine is equipped with high frequency Intel Xeon E5-2686 v4 (Broadwell) processors 2ith
16 vCPUs and a Tesla V100 GPU with 5,120 CUDA Cores and 640 Tensor Cores.

5.1 Using pretrained SciBERT and BioBERT models
This experiment was conducted to answer the first research questions by applying step 1
and step 2 in the methodology
Hypothesis
Initializing the system with SciBERT or BioBERT models would improve model
performance since these models are trained biomedical data.
Setup
For this experiment we will use the same setup in the baseline system, but we will be
changing the tokenizer and the base model to SciBERT and BioBERT. After tokenization and
data preparation, we will initialize the model with the pretrained weights from SciBERT and
BioBERT base models and train each for 3 epochs with learning rate 3e-5.
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Results and findings
Table 4 shows the results of this experiment:
Table 4 Experiment 1 results
Token level eval
SciBERT
BioBERT

Precision
23.07%
24.87%

Recall
33.34%
25.50%

F1 Score
27.27%
25.18%

In table 4 we can observe the results of finetuning both SciBERT and BioBERT models on
ChemProt dataset. The results observed for the SciBERT and BioBERT model are comparable to
those of the BERT base model, no significant improvement could be noticed.

5.2 Preprocessing Impact
This experiment was conducted to answer the second research question by applying
step 3 in the methodology section. This experiment is divided into two parts, the first is by
adding basic preprocessing rules and the second part is adding POS tagging to filter out less
meaningful parts of text.
Hypothesis
Dropping less meaningful tokens from training data passed to the model would
improve model performance.
5.2.1 Apply basic preprocessing rules
Setup
For this experiment we will add some basic preprocessing rules like dropping out
punctuation and stop words (articles, pronouns, prepositions, and conjunctions).
Results and findings
The following table shows the results of this experiment:
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Table 5 Experiment 2.1 results
Token level eval
BERT
(preprocessing)
SciBERT
(preprocessing)
BioBERT
(preprocessing)
Entity level eval
BERT
(preprocessing)
SciBERT
(preprocessing)
BioBERT
(preprocessing)

Precision

Recall

F1 Score

54.92%

84.19%

66.47%

61.06%

86.62%

71.63%

55.13%

85.39%

67.00%

Precision

Recall

F1 Score

16.15%

76.44%

26.66%

18.39%

78.62%

29.81%

16.60%

77.51%

27.35%

In table 5 we can observe the results of finetuning both SciBERT and BioBERT models on
ChemProt dataset while applying basic preprocessing rule. We can observe a significant
improvement of scores because of the added rules. This indicates that the filtered entities were
having a negative impact on the model performance. We can also observe higher scores for
SciBERT model while no significant improvement for BioBERT model. Precision: 61.06%, Recall:
86.62%, F1: 71.3%.
5.2.2 Part of speech tagging in preprocessing step
Setup
For this experiment we will add an extra step in preprocessing phase of data preparation
where we pass the whole abstract to a POS tagging module and based on the output of this
module; we remove verbs and adjectives from the text before passing to the model.
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Results and findings
The following table shows the results of this experiment:
Table 6 Experiment 2.2 results
Token level eval
SciBERT
(preprocessing)
SciBERT
(preprocessing + POS)
BioBERT
(preprocessing)
BioBERT
(preprocessing + POS)
Entity level eval
SciBERT
(preprocessing)
SciBERT
(preprocessing + POS)
BioBERT
(preprocessing)
BioBERT
(preprocessing + POS)

Precision

Recall

F1 Score

61.06%

86.62%

71.63%

65.93%

93.46%

77.32%

55.13%

85.39%

67.00%

55.18%

95.92%

70.06%

Precision

Recall

F1 Score

18.39%

78.62%

18.39%

46.02%

81.92%

58.94%

16.60%

77.51%

27.35%

40.52%

57.90%

47.68%

In the table above we can observe the results of adding POS tagging into the
preprocessing and finetuning on both SciBERT and BioBERT model. A significant increase in F1
score is observed when removing verbs and adjectives based on POS tagging in the
preprocessing step. Precision: 65.93%, Recall: 93.46%, F1:77.32%. A significant increase in F1
score is observed when removing verbs and adjectives based on POS tagging in the
preprocessing step.

5.3 Using DrugProt dataset
This experiment was conducted to answer the third research question by applying step 4
in the methodology.
Hypothesis
The increase in training data would improve the results.
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Setup
DrugProt [5] dataset which is a superset of the ChemProt training set will be used for
training instead of the training set of ChemProt. Since we are changing the dataset, we will
repeat the parameter tuning step to find optimal parameters to train the model with. After
initializing the model with both SciBERT and BioBERT base models. We train it for one of the
following epochs counts (3, 8 ,20) with one of the following learning rates (3e-4, 8e-5, 3e-5, 3e-6).
After we settle on the optimal parameters, we use both the training and development sets to
train the model and evaluate it on the test to measure the improvement with the change of the
dataset.
Results and findings
The following table shows the results of this experiment:
Table 7 Experiment 3 results
Token level eval
SciBERT
(ChemProt)
SciBERT
(DrugProt)
BioBERT
(ChemProt)
BioBERT
(DrugProt)
Entity level eval
SciBERT
(ChemProt)
SciBERT
(DrugProt)
BioBERT
(ChemProt)
BioBERT
(DrugProt)

Precision

Recall

F1 Score

65.93%

93.46%

77.32%

66.20%

98.96%

79.33%

55.18%

95.92%

70.06%

55.68%

99.48%

71.40%

Precision

Recall

F1 Score

46.02%

81.92%

58.94%

47.62%

77.34%

58.95%

40.52%

57.90%

47.68%

43.16%

55.19%

48.44%

Based on the finetuning step of this experiment, the best results are observed for
SciBERT when model is finetuned on DrugProt for 3 epochs with learning rate 3e-5 and for

35

BioBERT model when finetuned on DrugProt for 3 epochs with learning rate 3e-5. Based on the
results in Table 7, SciBERT model is outperforming BioBERT model. A significant increase in F1
score for SciBERT model is observed when DrugProt dataset is used in the training. Precision:
62.20%, Recall: 98.96%, F1: 79.33%.

5.4 Ensemble
This experiment was conducted to answer the fifth research question by applying step-6
in the methodology. This step will be split into 2 experiments, one of them is by using SciBERT,
BioBERT, BERT models in the ensemble classifiers. The other is by splitting the training data
among multiple SciBERT models and using them in the ensemble classifier.
Hypothesis
Combining the predictions of more than one model would improve the scores.
5.4.1 Different models
Setup
After preparing the training data from the DrugProt dataset we use three models, one
initialized with SciBERT, one initialized with BioBERT, and one initialized with BERT model
and train each of them according to their optimal parameters. After training the model we get
the predictions from each of the models and pass it to a voting layer that takes a vote from each
model and returns the label with the most votes.
Results and findings
The following table shows the results of this experiment:
Table 8 Experiment 4.1 results
Token level eval
SciBERT
(5.3)
SciBERT, BioBERT,
BERT
(Ensemble)

Precision

Recall

F1 Score

66.20%

98.96%

79.33%

62.56%

98.86%

76.63%
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Entity level eval
SciBERT
(5.3)
SciBERT, BioBERT,
BERT
(Ensemble)

Precision

Recall

F1 Score

47.62%

77.34%

58.95%

47.41%

75.28%

58.18%

Based on the observed results in Table 8, there is a drop in the scores which means that
the results from the other two models are lowering the performance of the SciBERT model.
5.4.2 Split dataset
Setup
After preparing the training data from the DrugProt dataset we split into multiple
separate sets, each set contains some randomly selected datasets from the training data. We
initialize multiple models with SciBERT base model and finetune it on each of the sets. After all
the models are trained, we pass their predictions into a voting layer that takes a vote from each
model and returns the label with the most votes.
Results and findings
The following table shows the results of this experiment:
Table 9 Experiment 4.2 results
Token level eval
SciBERT
(5.3)
SciBERT
5 models
dataset size 2000
(Ensemble)
SciBERT
5 models
dataset size 1500
(Ensemble)

Precision

Recall

F1 Score

66.20%

98.96%

79.33%

66.13%

99.00%

79.30%

66.06%

98.95%

79.23%
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SciBERT
7 models
dataset size 1500
(Ensemble)
Entity level eval
SciBERT
(5.3)
SciBERT
5 models
dataset size 2000
(Ensemble)
SciBERT
5 models
dataset size 1500
(Ensemble)
SciBERT
7 models
dataset size 1500
(Ensemble)

66.08%

98.94%

79.24%

Precision

Recall

F1 Score

47.62%

77.34%

58.95%

48.21%

77.24%

59.36%

47.71%

73.92%

58.00%

48.27%

76.36%

59.15%

Based on the observed results in Table 9, there is a slight drop in the scores when
splitting the dataset, regardless of the count of splits or the size of the dataset, there seems to be
no improvement in the scores.

5.5 Hierarchical entity extraction
This experiment was conducted to answer the sixth research question by applying step-7
in the methodology.
Hypothesis
By building a 2-level extraction system, a first level to extract CHEM and GENE entities
and a second level to classify between GENE-N and GENE-Y named entities, this would lead to
better overall performance.
Setup
After preparing the training data from the DrugProt dataset, we create a version of it
where we join the GENE-N and GENE-Y entities under a common class “GENE”. We train a 2-
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level extraction system, the first level classifies the data into CHEMICAL or GENE and the
second level classifies the data into GENE-N or GENE-Y. We pass the test data into the first
model, if the label is GENE, we pass it into the second model to classify it into GENE-N or
GENE-Y.
Findings and results
The following table shows the results of this experiment:
Table 10 Experiment 5 results
Token level eval
SciBERT
(5.3)
SciBERT
CHEM-GENE classifier
SciBERT
GENE-N-GENE-Y
classifier
SciBERT hierarchical
Entity level eval
SciBERT
(5.3)
SciBERT
CHEM-GENE classifier
SciBERT
GENE-N-GENE-Y
classifier
SciBERT hierarchical

Precision

Recall

F1 Score

66.20%

98.96%

79.33%

78.40%

99.14%

87.56%

56.38%

83.58%

67.34%

66.28%

98.71%

79.31%

Precision

Recall

F1 Score

47.62%

77.34%

58.95%

57.11%

80.36%

66.77%

23.57%

81.28%

36.54%

47.67%

77.14%

58.93%

Based on the results in Table 10, the hierarchical recognition system didn’t improve the
results however when observed the results of the level 1 classifier between CHEM and GENE,
there is a significant improvement in scores verifying that the confusion is coming from GENEN and GENE-Y classification, as they have a close semantic meaning and may come up in
similar contexts which makes the distinction between them harder.
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5.6 Token level, and entity level evaluation analysis
As observed from the above experiments there is drop in the scores between token level
evaluation and named entity evaluation. This is expected as entity level evaluation doesn’t give
partial score to entities that were extracted correctly but treats all tokens in a named entity as
one. You can view this in the example highlighted on Figure 8 below

Figure 8 Evaluation Analysis

Taking the above tokens as an example, the token level analysis for those would be TP:
5, TN: 0, FP: 3 and FN: 4. Precision: 62.50%, Recall: 55.56%, F1: 58.82%. However, for entity level
evaluation the first entity “terpenoids” out of its 3 tokens, only one token was predicted
correctly so it was given a wrong label, same thing with second entity, the third entity is given
the correct token although one of its tokens was not predicted correctly. For entity level
evaluation we have TP: 1, TN: 0, FP: 1 and FN:1. Precision: 50.00%, Recall: 50.00%, F1: 50.00%.
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Chapter 6

Conclusion and Future Work
Throughout this research, we have built a baseline system by initializing the model with
BERT base model and finetuned it on the ChemProt dataset. Next, we experimented by
initializing the model with SciBERT or BioBERT instead of BERT and we did a parameter tuning
experiment to find the optimal model parameters. We also experimented with applying basic
preprocessing rules and filtering out verbs and adjectives based on POS tagging. We also
experimented with the DrugProt dataset to increase the training data size. Further experiments
were conducted for Ensemble classifiers and hierarchical entity extraction models.
Based on the conducted experiments our findings are that initializing your system with
SciBERT pre trained model and fine tuning it with ChemProt dataset has better results over
other BERT variations. We also found out that applying preprocessing to the training data has a
significant positive impact over model performance. Also filtering out verbs and adjectives by
adding POS tagging to the preprocessing phase. With the release of DrugProt [5] dataset, a
newer version of chemprot dataset we have the chance of increasing the training data which
also have a positive impact over model performance. It is also worth noting that we have
implemented two methods for evaluation, token level evaluation, entity level evaluation, the
first one evaluates the model based on the prediction per token. The second method takes into
account the exact entity and only counts a successful recognition if the whole entity was
extracted and given the correct label. As expected scores from the second method are lower
than that of the first method as they require higher certainty.
So, coming back to the research questions; to answer the first question, initializing the
system with SciBERT model yields better results when it comes to extracting named entities
from biomedical text. This can be observed throughout the experiments that SciBERT model has
the best scores. To answer the second question preprocessing the data before passing it the
model have a significant impact in improving model performance, this can be observed with the
significant improvement with basic preprocessing and further improvement when POS tagging
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is added to these rules. To answer the third question, increasing the size of training data using
the DrugProt dataset improves model performance. To answer the fourth question, using
ensemble classifiers didn’t improve the overall system performance. To answer fifth question,
building a hierarchical extraction model didn’t improve model performance but identified that
a significant reason for the drop in scores comes from the model’s inability to distinguish
between the different types of genes in the text.
To conclude, the best performance could be achieved by removing punctuation, stop
words verbs and adjectives from the text and finetuning with SciBERT pretrained model with
learning rate 3e-5 for 3 epochs, token level evaluation: Precision: 66.20%, Recall: 98.96%, F1:
79.33%, entity level evaluation: Precision: 47.62%, Recall: 77.34%, F1: 58.95%. NCBI-Disease
corpus [47] is one of the common benchmark dataset in the field of biomedical NER. F1 score
for NCBI dataset with Spark NLP [48] model is 90.48% and with BioBERT model[3], F1 is
89.71%.
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